The FDA has approved a new blood test to detect Alzheimer’s disease, and the government shutdown delays the 2026 ...

A second blood test has been been approved by the US Food and Drug Administration to assist in diagnosing Alzheimer’s disease ...

The U.S. Food and Drug Administration has cleared another blood test that could help doctors identify whether memory problems ...

Neurologists at Florida Atlantic University have launched a new research tool combining focused ultrasound and magnetic ...

Previous research investigating sex differences in brain ageing has shown mixed results, Ravndal adds. Several studies have ...

Benzodiazepines and antipsychotics given to hospice patients with dementia appear to increase their risk of earlier death, ...

A secondary analysis of TRAILBLAZER-ALZ 2 strengthens the case that reducing amyloid plaques underlies the clinical benefits ...

The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other ...

Doug Whitney, 76, carries a rare PSEN2 genetic mutation that causes early-onset Alzheimer's but shows no cognitive decline ...

In May, the FDA cleared the first blood-based diagnostic test for Alzheimer's disease, the Lumipulse G pTau 217/β-Amyloid ...

Roche Diagnostics said on Monday the U.S. Food and Drug Administration cleared its and partner Eli Lilly's blood test as an ...